Patent · US Active

Humanized anti-interleukin 3 receptor alpha chain antibodies

US10047161B2 · kind B2 · utility

2Cited by
1References
4Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 3, 2015
Grant dateAug 14, 2018
Priority date—
Expiry dateApr 3, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides antibodies that bind to interleukin-3 receptor alpha chain and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.